NPPA-AS1: A Potential Drug Target and Biomarker (G100379251)
NPPA-AS1: A Potential Drug Target and Biomarker
Non-Protein-Amino Acid-Containing Structures (NPAs) have been identified as potential drug targets in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. One of the most promising structures is the N-acylated small molecule, called NPPA-AS1, which has been shown to interact with several protein-protein interfaces and has been identified as a potential drug target in multiple diseases.
NPPA-AS1 is a small molecule that is derived from the amino acid Asp. It has a N-acylated side chain, which consists of an amino acid that is attached to the nitrogen atom of the side chain. The N-acylated side chain is a common structural feature that has been observed in various proteins, including enzymes, G-protein-coupled receptors, and other transmembrane proteins.
One of the unique features of NPPA-AS1 is its ability to interact with protein-protein interfaces. This interaction can lead to the formation of inclusion complexes, which can be stable and have been observed to affect protein function. NPPA-AS1 has been shown to interact with a variety of protein-protein interfaces, including those between the cytoskeleton and the endoplasmic reticulum, and between different cell types.
In addition to its ability to interact with protein-protein interfaces, NPPA-AS1 has also been shown to have a unique biological activity. Studies have shown that NPPA-AS1 can induce cell death in various cell types, including cancer cells, and that it can also inhibit the growth of cancer cells. This suggests that NPPA-AS1 may have a potential as a cancer therapeutic.
The N-acylated small molecule has also been identified as a biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that NPPA-AS1 may be a useful tool for the diagnosis and treatment of these diseases.
NPPA-AS1 has been shown to interact with several protein-protein interfaces, including those between the cytoskeleton and the endoplasmic reticulum. This interaction suggests that NPPA-AS1 may have a role in regulating cellular processes that are important for the cytoskeleton and the endoplasmic reticulum.
In addition to its potential role in cellular processes, NPPA-AS1 has also been shown to have a unique biological activity. Studies have shown that NPPA-AS1 can induce cell death in various cell types, including cancer cells, and that it can also inhibit the growth of cancer cells. This suggests that NPPA-AS1 may have a potential as a cancer therapeutic.
The N-acylated small molecule has also been identified as a biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that NPPA-AS1 may be a useful tool for the diagnosis and treatment of these diseases.
In conclusion, NPPA-AS1 is a small molecule that has been shown to interact with several protein-protein interfaces and has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further studies are needed to fully understand its unique biological activity and potential as a therapeutic.
Protein Name: NPPA Antisense RNA 1
More Common Targets
NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3
